Literature DB >> 2528548

Generation of IL-1-like activity in response to biomedical polymer implants: a comparison of in vitro and in vivo models.

K M Miller1, V Rose-Caprara, J M Anderson.   

Abstract

Of the many factors determining host biocompatibility responses to implanted biomedical polymers, the cellular interactions at the tissue/material interface have been recognized to be some of the most important. The present study has combined results both from an in vitro cell culture system and from an in vivo animal model to examine this host response. In vitro results suggest that a variety of polymer materials can differentially activate human monocytes to produce a protein(s) having different biological activities. The polymers tested induce the production of the regulatory inflammatory protein interleukin 1 as well as a factor that enhances fibroblast proliferation and collagen synthesis. The observed activities of these factors appear to be related but not identical, and are dependent upon the specific polymer. Evaluation of exudate and tissue responses to these same polymer materials in an in vivo model are also presented. Both in vitro and in vivo results support the hypothesis that monocyte/macrophage activation with subsequent synthesis of regulatory factors such as interleukin 1 plays a significant role in determining the host response to biomedical polymer implants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528548     DOI: 10.1002/jbm.820230904

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  15 in total

1.  Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

Authors:  A Y Annenkov; A G Strokov; F S Baranova
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro.

Authors:  Paige C S Bota; Angela M B Collie; Pauli Puolakkainen; Robert B Vernon; E Helene Sage; Buddy D Ratner; Patrick S Stayton
Journal:  J Biomed Mater Res A       Date:  2010-11       Impact factor: 4.396

3.  Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure.

Authors:  D R Cole; M Waterfall; M McIntyre; J D Baird
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

Review 4.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

Review 5.  Mesh biocompatibility: effects of cellular inflammation and tissue remodelling.

Authors:  Karsten Junge; Marcel Binnebösel; Klaus T von Trotha; Raphael Rosch; Uwe Klinge; Ulf P Neumann; Petra Lynen Jansen
Journal:  Langenbecks Arch Surg       Date:  2011-04-01       Impact factor: 3.445

6.  Correlation of cytokine elaboration with mononuclear cell adhesion to platelet storage bag plastic polymers: a pilot study.

Authors:  I ElKattan; J Anderson; J K Yun; E Colton; R Yomtovian
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

7.  Lymphoid activation by micro- and macroencapsulated islets during mixed lymphocyte islet culture.

Authors:  T Zekorn; H Entenmann; A Horcher; U Siebers; G Klöck; U Zimmermann; K Federlin; R G Bretzel
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Synthesis of macroporous poly(dimethylsiloxane) scaffolds for tissue engineering applications.

Authors:  Eileen Pedraza; Ann-Christina Brady; Christopher A Fraker; Cherie L Stabler
Journal:  J Biomater Sci Polym Ed       Date:  2012-10-31       Impact factor: 3.517

Review 9.  The immunopathology of siliconosis. History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone.

Authors:  D R Shanklin; D L Smalley
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

10.  Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites.

Authors:  Analiz Rodriguez; Howard Meyerson; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2009-04       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.